Somatix and Roche Launch an Only-of-Its-Kind Medication Compliance Capability Using AI-Enabled Wearable Technology
NEW YORK, NY / ACCESSWIRE / July 11, 2023 / Somatix leadership presented the results of its brand-new medication compliance...
Day: July 11, 2023
Somatix and Roche Launch an Only-of-Its-Kind Medication Compliance Capability Using AI-Enabled Wearable Technology
NEW YORK, NY / ACCESSWIRE / July 11, 2023 / Somatix leadership presented the results of its brand-new medication compliance...
AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities
CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine...
AMD Global Telemedicine and Collain Healthcare Announce Strategic Partnership to Revolutionize Healthcare Delivery in Senior Living Facilities
CHELMSFORD, MA / ACCESSWIRE / July 11, 2023 / AMD Global Telemedicine Inc. (AMD), a renowned global leader in telemedicine...
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
For Fourth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 ScholarshipLAVAL, QC / ACCESSWIRE / July...
Salix Announces 2023 Gastrointestinal Health Scholars Program Winners
For Fourth Consecutive Year, 10 Students with Gastrointestinal Disease Will Each Receive a $10,000 ScholarshipLAVAL, QC / ACCESSWIRE / July...
Avant Brands Announces Q2 2023 Earnings Conference Call Details
KELOWNA, BC / ACCESSWIRE / July 11, 2023 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
Avant Brands Announces Q2 2023 Earnings Conference Call Details
KELOWNA, BC / ACCESSWIRE / July 11, 2023 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
Veteran Healthcare Communicator Lea Sims Appointed to Lead CGFNS Marketing and Communications
PHILADELPHIA, PA / ACCESSWIRE / July 11, 2023 / CGFNS International announced today that it has appointed Lea Sims, a...
Veteran Healthcare Communicator Lea Sims Appointed to Lead CGFNS Marketing and Communications
PHILADELPHIA, PA / ACCESSWIRE / July 11, 2023 / CGFNS International announced today that it has appointed Lea Sims, a...
AlayaCare Welcomes US Health Care Executive Chris Hare as CRO
AlayaCare Bolsters Leadership Team to Accelerate Growth and US ExpansionTORONTO, ON / ACCESSWIRE / July 11, 2023 / AlayaCare, an...
AlayaCare Welcomes US Health Care Executive Chris Hare as CRO
AlayaCare Bolsters Leadership Team to Accelerate Growth and US ExpansionTORONTO, ON / ACCESSWIRE / July 11, 2023 / AlayaCare, an...
Company’s Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness in RSV in a Lethal Lung Disease Animal Model, Reports NanoViricides
SHELTON, CT / ACCESSWIRE / July 11, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development...
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
Award Recognizes Efforts to Raise Awareness Around Non-Drug Depression TreatmentMALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
Key GBB Drink Lab Executives to Join Jupiter Wellness’ C-Suite. Josh Wagner and David Sandler Will Bring Their Experience and Knowledge to Jupiter Wellness as it Deploys a Multi-Channel Strategy to Bring Safety Shot to Market
Jupiter Wellness, Inc Jupiter Wellness as it Deploys a Multi-Channel Strategy to Bring Safety Shot to MarketJUPITER, FL, July 11,...
Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults
The Phase 3 clinical trials achieved the co-primary and all secondary endpoints and subjects completed the 16-week treatment with no...
Eterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors
CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science...
Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings
CHARLOTTESVILLE, Va., July 11, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical...